Clinical Trials Logo
  1. Home
  2. Mucositis Oral
  3. NCT03983369

Low-level Laser Therapy in the Prevention of Chemotherapy-induced Mucositis in Children and Young Adults — MUCILA  

Mucositis Oral Clinical Trial

Official title:
Multicenter Double Blind Randomized Placebo-controlled Trial Assessing the Efficacy of Low-level Laser Therapy in the Prevention of Chemotherapy-induced Mucositis in Children and Young Adults

Clinical Trial Summary

To assess the efficacy of preventive Low-Level Laser Therapy (LLLT) for reducing the incidence of WHO's grade 3-4 oral mucositis in children and young adults receiving chemotherapy regimens associated with a high rate of mucositis: conventional chemotherapy or High Dose Chemotherapy (HDC) conditioning regimens with Hematological Stem Cell Transplantation (HSCT).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03983369
Study type Interventional
Source Gustave Roussy, Cancer Campus, Grand Paris
Contact Léa Guerrini-Rousseau, MD
Phone +33 (0)1 42 11 67 41
Email lea.guerrini-rousseau@gustaveroussy.fr
Status Recruiting
Phase Phase 3
Start date August 29, 2018
Completion date September 2023
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT05331131 - Efficacy of Ketamine Mouthwash in the Management of Oral and Pharyngeal Toxicity Associated With Head and Neck Chemoradiotherapy: A Phase 2, Simon 2-stage Trial Phase 2
Not yet recruiting NCT06031012 - Glutamine Combined With Thalidomide in Preventing Radiation-induced Oral Mucositis Phase 3
Not yet recruiting NCT04080622 - Evaluate the Efficacy of Selenium for the Prevention of Chemotherapy-induced Mucositis During Autologous Stem Cell Transplantation. Phase 3
Recruiting NCT06217224 - Evaluation of Prophylactic Photobiomodulation Therapy in Patients With Osteosarcoma N/A
Completed NCT03416582 - Feasibility Study of a Nurse Intervention to Impact Mucositis Severity and Prevent Dehydration N/A
Completed NCT03577535 - Evaluation of ONCOXIN® in Oral Mucositis, Appetite and Body Mass in Cancer Patients. Phase 2
Recruiting NCT04596410 - Photobiomodulation Protocols in the Analgesia of Chemotherapy-induced Oral Mucositis in Children N/A
Recruiting NCT05278260 - Hydrogen-rich Water and Treatment of Mucositis Caused by Radiation Therapy in Head and Neck Cancer Patients N/A
Recruiting NCT05308732 - Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy Phase 1
Completed NCT00293462 - GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer Phase 3
Recruiting NCT05926297 - Treatment of Peri-implant Mucositis by Sodium Hypochlorite Gel and Cross-linked Hyaluronic Acid Gel N/A
Recruiting NCT04671862 - Photobiomodulation for the Prevention of Radiation Induced Oral Mucositis N/A
Recruiting NCT05926557 - Treatment of Peri-implant Mucositis by Application of a Spermidine-based Gel N/A
Completed NCT04187222 - Effect of Probiotic Use Bifidobacterium Animalis Subsp. Lactis in Peri-implant Mucositis Phase 3
Completed NCT05307445 - Treatment of Peri-Implant Mucositis With Standard of Care and Bioptron Hyperlight Therapy N/A
Completed NCT05214495 - Omega-3 Hydrogel and Prevention of Oral Mucositis Phase 2/Phase 3
Not yet recruiting NCT04303312 - Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis Phase 3
Completed NCT06049511 - Oral Self Care Protocol and Oral Mucositis N/A
Not yet recruiting NCT05224882 - Chemotherapy Oral Manifestations and Dental Awareness Among Parents
Active, not recruiting NCT03461354 - MucoLox Formulation to Mitigate Mucositis Symptoms in Head/Neck Cancer N/A